"10.1371_journal.pone.0138111","plos one","2015-09-14T00:00:00Z","Magnus Gram; Ulrik Dolberg Anderson; Maria E Johansson; Anneli Edström-Hägerwall; Irene Larsson; Maya Jälmby; Stefan R Hansson; Bo Åkerström","Lund University, Department of Clinical Sciences Lund, Infection Medicine, Lund, Sweden; Lund University, Department of Clinical Sciences Lund, Obstetrics and Gynecology, Lund, Sweden","Conceived and designed the experiments: MG SRH BÅ. Performed the experiments: MG UDA MEJ AEH IL MJ SRH BÅ. Analyzed the data: MG UDA MJ SRH BÅ. Wrote the paper: MG UDA MJ SRH BÅ.","The authors have read the journal's policy and the authors of this manuscript have the following competing interests: The authors MG, BÅ, and SRH are co-founders of the company A1M Pharma AB and holds patents regarding diagnosis and treatment of preeclampsia. These patents include 'Biomarkers for preeclampsia' (Appl. no. PA 2015 70146, filed 13/3 2015), 'Fetal hemoglobin (HbF) and alpha-1-microglobulin (A1M) as early stage markers for preeclampsia' (PCT/EP2011/001458, priority date 24/3 2010), and 'Diagnosis and treatment of preeclampsia' (PCT/EP2008/001051, priority date 12/2 2007). This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.","2015","09","Magnus Gram","MG",8,TRUE,3,8,5,5,TRUE,TRUE,FALSE,0,NA,FALSE
